Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Generic Sweden

39,80 SEK+0,76 %28.8, 9.21
Mindre end 1K følgere

GENI

First North Stockholm

IT Services

Technology

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorernes syn
Sammenligne
+0,76 %
+6,28 %
-0,62 %
+5,71 %
-14,22 %
-21,34 %
-8,08 %
-53,07 %
+67,97 %

Generic Sweden operates in the IT sector. The company offers a platform for digital communication services that are integrated into customers' internal or external communication flows. The services are provided through a CPaaS model (Communication Platform as a Service). The company's customers are found in several sectors with a particular position in alarms and security, healthcare and e-health, and e-commerce. The company was founded in 1993 and is headquartered in Stockholm.

Læs mere
Markedsværdi
489,22 mio. SEK
Aktieomsætning
117,86 t SEK
Omsætning
183,72 mio.
EBIT %
21 %
P/E
15,79
Udbytteafkast, %
4,4 %
Omsætning og EBIT-margin
EPS og udbytte
Finanskalender
Alle
Eksterne analyser
ViserAlle indholdstyper

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
12.11
2026

Delårsrapport Q3'26

11.2
2027

Årsrapport '26

13.5
2027

Delårsrapport Q1'27

Eksterne analyser24.08.2026, 07.10

Generic: Investing while growing - ABG

* A better mix of growth drivers * Costs reflect investments in the organisation * EV/adj. EBIT of 10-9x '26e-'27e, 55% below its peers Growth on a broader base Generic Sweden reported Q2 sales of SEK 49m, up 10% y-o-y, in line with our expectations....

Generic Sweden
Eksterne analyser20.08.2026, 07.53

Generic: Volumes continue to grow - ABG

* Volumes strong, sales up 10% y-o-y * Adj. EBIT growth of 8% y-o-y, margin of 21% * DOCS now penetrated >30% of municipalities Q2'26 details Generic Sweden reported Q2'26 sales of 48.7m, in line with our expectations (0% vs ABGSCe 48.7m), mostly driven...

Generic Sweden
Eksterne analyser11.08.2026, 13.53

Generic: The growth journey continues - ABG

* We expect growth to return in a seasonally soft quarter * Estimates unchanged but costs elevated near term * EV/adj. EBIT of 10/9x '26e/'27e, ~60% below peers Volume recovery holds Generic reports its Q2 on 20 August. We think the recovery in Messaging...

Generic Sweden

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser20.05.2026, 07.06

Generic: Broadening verticals lift the mix - ABG

* Volume growth in coming quarters * Growing verticals will likely add some costs * EV/EBIT of 10x '26e and 9x '27e Likely past the bottom of the cycle Volumes came in above our expectations. The Messaging segment (SMS, RCS, SenderID), Generic's largest...

Generic Sweden
Eksterne analyser13.05.2026, 08.24

Generic: Volumes back in business - ABG

* Volumes stronger than expected * Gross margin continues to be steady at ~44% * DOCS now penetrated >30% of municipalities Q1'26 details Generic reported Q1'26 sales of SEK 49m, 9% y-o-y growth (+6% vs ABGSCe 46m), driven by higher volumes in the SMS...

Generic Sweden
Eksterne analyser11.05.2026, 07.09

Generic: Bottoming before the bounce - ABG

* Volumes likely soft in Q1 * Management changes to weigh on earnings * EV/EBIT of 10-9x on '26e-'27e, ~60% below its CPaaS peers Likely at the bottom of the cycle The market continues to be weighed by pricing pressure and customers holding back on spending...

Generic Sweden
Eksterne analyser16.02.2026, 07.23

Generic: The gross margin story remains strong - ABG

* Sales up 3% y-o-y, held back by soft volumes and tough comps * We keep sales flat, and slightly raise opex * Trading at 9-8x on '26e-'27e EV/EBITA, below its historical median Recruiting and consulting costs weighing on EBIT Generic reported an in-...

Generic Sweden
Eksterne analyser12.02.2026, 10.48

Generic: Gross margins up but costs weigh in Q4 - ABG

* Sales -1% and adj. EBITA -5% vs ABGSCe * Gross profit of SEK 21.5m, up 5% y-o-y, and GM of 44% * SaaS continues to grow, DOCS adoption >26% of municipalities Q4'25 details Generic reports Q4'25 sales of SEK 49.2m (-1% vs ABGSCe 49.7m), broadly in line...

Generic Sweden
Eksterne analyser04.02.2026, 07.23

Generic: Margins over volumes - ABG

* Q4 growth partly offset by SMS volumes * Raising EBITA by 7-6% for '26e-'27e * 11-9x EV/EBITA on '26e-'27e, ~20% below historical median Softer quarter due to volumes Generic reports its Q4'25 on 12 February, and we expect sales of SEK 50m, representing...

Generic Sweden
Eksterne analyser19.11.2025, 16.32

Generic: Scaling efficiently for margin improvement - ABG

* Continued margin expansion driven by DOCS* EBIT estimates raised by 2-3% for '26e-'27e on scaling potential* Trading at 13x EV/EBIT, ~20% below its historical medianGrowing SaaS contributionGeneric reported a slightly better Q3, with sales of SEK 45m...

Generic Sweden
Eksterne analyser12.11.2025, 08.24

Generic: Margin expansion driven by SaaS - ABG

* Sales +3% and adj. EBITA +14% vs ABGSCe* DOCS adoption >24% of municipalities* Consensus adj. EBIT likely up mid single-digits Q3'25 details Generic reports Q3'25 sales of SEK 45m (+3% vs. ABGSCe 44m), supported by new contracts and an improved product...

Generic Sweden
Eksterne analyser21.10.2025, 07.26

Generic: Margin stability in a softer market - ABG

* Seasonally weaker volumes to weigh on earnings* 10-12% '26e-'27e sales growth, 21-22% EBIT margin* Trading at 12x EV/EBITA in '26e, ~15% below historical medianExpect usual seasonal impact on Q3 numbersGeneric reports its Q3'25 on 12 November, and ...

Generic Sweden
Eksterne analyser25.08.2025, 07.27

Generic: Communication flows, margin grows - ABG

* Gross margin at 45% (40%)* SaaS supports margins and outlook* Trading at ~11-9x EV/EBITA for '26e-'27eStrong margin improvementGeneric reported sales of SEK 44m, up 2% y-o-y (4% below ABGSCe), driven by: i) lower volume-based products (e.g. SMS), which...

Generic Sweden
Eksterne analyser21.08.2025, 10.03

Generic: Margins holding up well - ABG

* Sales -4% and adj. EBIT -11% vs ABGSCe* DOCS adoption >23% of municipalities* Consensus adj. EBIT likely down by mid single-digitsQ2'25 detailsGeneric reports Q2'25 sales of SEK 44.3m (-4% vs ABGSCe 46.2m), impacted by mix effects and smaller-sized...

Generic Sweden
Eksterne analyser23.05.2025, 14.28

Generic: Scalability on show - ABG

6% organic sales growth y-o-y SaaS momentum drives gross margin uplift... ... and leads to impressive EBIT growth of 41% y-o-y Q1: Sales growth of 6%, EBIT margin of 21.7% (16.3%) The Q1 report really showed the scalability of Generic's business model...

Generic Sweden
Eksterne analyser18.02.2025, 11.48

Generic: Ends 2024 in style - ABG

24% organic sales growth y-o-y Improved gross margin due to pricing and mix Opex flat y-o-y leads to 48% EBIT growth Q4: Sales growth of 24%, EBIT margin of 22.7% (19.0%) Generic continued its impressive comeback in Q4, where H1'24 profitability issues...

Generic Sweden
Eksterne analyser15.11.2024, 15.52

Generic: Strong quarter and outlook - ABG

24% organic sales growth y-o-y Improved gross margin due to price adjustments Opex growth to abate in the coming quarters Q3: Sales growth of 24%, EBIT margin of 20.6% (22.6%) In our view, Generic's Q3 results were impressive. Sales growth remained strong...

Generic Sweden
Eksterne analyser23.08.2024, 07.30

Generic: Strong growth, temporarily lower profitability - ABG

26% organic sales growth y-o-y Growth initiatives hurt profitability mid-term Pricing to act as a tailwind for gross margin in Q3 Q2: Sales growth of 26%, EBIT margin of 15.5% (20%) There was a similar trend in Generic's Q2 numbers as we saw in Q1, where...

Generic Sweden
Eksterne analyser17.05.2024, 11.45

Generic: Prioritising growth over margins - ABG

22% organic sales growth y-o-y Lower than expected gross margin Price increases should help gross margin in Q2 Q1: Sales growth of 22%, EBIT margin of 16.3% (21.3%) Generic's Q1 numbers were quite eventful as there was a new strategic direction prioritising...

Generic Sweden
Eksterne analyser22.02.2024, 08.38

Generic: 2024 outlook still looks solid - ABG

12% organic sales growth y-o-y Opex increase and IAC affect Q4 Profitability assumptions down on slightly higher opex Q4: Sales growth of 12%, adj. EBIT margin of 19% (21.5%) Generic reported Q4 numbers were slightly behind our expectations. Net sales...

Generic Sweden